


Healthcare | Small Cap
Indegene Ltd shows a strong financial profile characterized by high growth and exceptional profitability. The company is expanding its sales and assets at a rapid pace, indicating strong market demand for its services. Its financial foundation is remarkably solid, with very little reliance on debt, which significantly lowers its financial risk. This allows the company to comfortably cover all its obligations. However, there are areas of concern, particularly in its operational efficiency. The company takes a long time to collect payments from its customers, which can affect its cash flow. Despite overall profit growth, the earnings per individual share have seen a decline, which is a point of concern. The company is currently focused on reinvesting its earnings back into the business for future growth.
Indegene Ltd shows a strong financial profile characterized by high growth and exceptional profitability. The company is expanding its sales and assets at a rapid pace, indicating strong market demand for its services. Its financial foundation is remarkably solid, with very little reliance on debt, which significantly lowers its financial risk. This allows the company to comfortably cover all its obligations. However, there are areas of concern, particularly in its operational efficiency. The company takes a long time to collect payments from its customers, which can affect its cash flow. Despite overall profit growth, the earnings per individual share have seen a decline, which is a point of concern. The company is currently focused on reinvesting its earnings back into the business for future growth.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
57.88
Industry Median
30.48
Small Cap Median
30.48
P/E RATIO
30.59
P/B RATIO
3.92
Industry Median
3.56
Small Cap Median
3.56
P/S RATIO
3.54
Industry Median
3.21
Small Cap Median
3.21
Others
PEG RATIO
1.40
EV/EBITDA RATIO
18.20
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹509.3 as on Jul 10, 2026.
The company is in a strong growth phase, marked by excellent expansion in revenue and assets. This indicates successful market penetration and a high demand for its services. However, this impressive top-line growth does not translate down to earnings per share, which has seen a decline. This suggests that while the business itself is growing, the value distributed to each individual share is being diluted, possibly due to an increase in the number of shares to fund this expansion.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 72.36 | 38.5 | 12.32 | 9.61 | 23.64 |
| Operating Profit Growth Rate | 24.78 | 37.98 | 27.53 | 8.51 | 12.96 |
| Earnings Per Share (EPS) Growth | -1.49 | -98.72 | 26.27 | 11.96 | -1.77 |
| Asset Growth Rate | 127.01 | 62.9 | 15.52 | 30.64 | 38.91 |
| Net Income Growth Rate | 9.4 | 63.19 | 26.69 | 20.77 | -1.47 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Vijaya Diagnostic Centre Ltd | 8.44 | 82.64 | Neutral | 337.00 | 17.33 | 173.00 |
| 2 | Metropolis Healthcare Ltd | 7.76 | 61.94 | Neutral | 401.00 | 7.58 | 191.00 |
| 3 | Indegene Ltd | 7.58 | 30.59 | Neutral | 619.00 | 8.80 | 401.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Concall Report⬤3rd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Annual Report⬤2nd Jul 26
Annual Report 2025-26
UNDEFINED SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT